Avenue Therapeutics Inc is a pharmaceutical company focused on the development of innovative therapies for the treatment of various medical conditions, primarily within the realm of pain management
The company is dedicated to advancing its pipeline of drug candidates, leveraging scientific research and clinical expertise to address unmet needs in healthcare. Avenue Therapeutics aims to bring new options to patients and healthcare providers, with a commitment to improving quality of life through its therapeutic solutions.
Avenue Therapeutics shares are trading lower by 20.7% during Monday's session. The company announced the exercise of warrants for $4.4 million in gross proceeds.
Shares of Mesoblast Limited (NASDAQMESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday.
Shares of Fangdd Network Group Ltd. (NASDAQDUO) rose sharply in today’s pre-market trading after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector. Fangdd Network Group shares jumped 78.3% to $1.08 in pre-market trading
Avenue Therapeutics Inc (NASDAQATXI) shares are trading lower by 31% to $0.24 Friday morning after the company announced it has entered into warrant exercise agreements with existing
